HSPH1 and colorectal carcinoma: Regarding these discordant results, HSP110 IHC score or size of HSP110 T17 deletion are neither robust prognostic biomarkers nor predictive factors of adjuvant chemotherapy efficacy in dMMR/MSI CRC.